April 3, 2025- Premier Inc. issued a statement addressing recent tariff announcements by the White House. The company emphasizes the importance of a comprehensive strategy that leverages tariff revenues to expand domestic and nearshore manufacturing of essential medical products. This approach aims to mitigate potential disruptions in the healthcare supply chain and ensure the continued availability of critical supplies for patient care.
“Targeted and thoughtful tariffs on healthcare products could offer a chance to bolster supply resilience and ensure access to critical medical supplies,” wrote Soumi Saha, Senior Vice President of Government Affairs, Premier Inc. “But they cannot live in a vacuum, lest they become just another cost without real impact. Premier believes that tariffs need to be put to work, funding innovation that ensures long-term stability and a stronger, more resilient U.S. supply chain.
In a previous communication, Premier responded to the administration’s call for input on trade policies, recommending that any unified trade policy minimize impacts on the U.S. healthcare supply chain. They advised clearly defining which healthcare products are subject to tariffs, implementing tariffs gradually to allow manufacturers and providers time to adjust, considering FDA approval timelines when shifting supply sources, and increasing supply chain transparency by publicly reporting the country of origin for federally purchased healthcare products. Premier
These recommendations reflect Premier’s commitment to shielding healthcare providers and patients from potential price increases and shortages resulting from tariff actions.
Continue Reading from the IDN Directory.